- Home
- APA vs RVMD Comparison
APA vs RVMD Comparison
Compare APA & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APA
- RVMD
- Stock Information
- Founded
- APA 1954
- RVMD 2014
- Country
- APA United States
- RVMD United States
- Employees
- APA N/A
- RVMD N/A
- Industry
- APA Oil & Gas Production
- RVMD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- APA Energy
- RVMD Health Care
- Exchange
- APA Nasdaq
- RVMD Nasdaq
- Market Cap
- APA 8.8B
- RVMD 7.5B
- IPO Year
- APA N/A
- RVMD 2020
- Fundamental
- Price
- APA $24.49
- RVMD $48.06
- Analyst Decision
- APA Hold
- RVMD Strong Buy
- Analyst Count
- APA 18
- RVMD 15
- Target Price
- APA $22.94
- RVMD $74.47
- AVG Volume (30 Days)
- APA 7.3M
- RVMD 2.3M
- Earning Date
- APA 11-05-2025
- RVMD 11-05-2025
- Dividend Yield
- APA 4.07%
- RVMD N/A
- EPS Growth
- APA N/A
- RVMD N/A
- EPS
- APA 2.94
- RVMD N/A
- Revenue
- APA $9,804,000,000.00
- RVMD N/A
- Revenue This Year
- APA N/A
- RVMD N/A
- Revenue Next Year
- APA N/A
- RVMD $454.11
- P/E Ratio
- APA $8.36
- RVMD N/A
- Revenue Growth
- APA 11.98
- RVMD N/A
- 52 Week Low
- APA $13.58
- RVMD $29.17
- 52 Week High
- APA $27.22
- RVMD $62.40
- Technical
- Relative Strength Index (RSI)
- APA 62.28
- RVMD 67.15
- Support Level
- APA $24.38
- RVMD $45.80
- Resistance Level
- APA $25.53
- RVMD $49.50
- Average True Range (ATR)
- APA 0.87
- RVMD 1.51
- MACD
- APA -0.08
- RVMD 0.07
- Stochastic Oscillator
- APA 74.95
- RVMD 79.17
About APA APA Corporation
APA Corp is an independent exploration and production company. It develops, and produces crude oil, natural gas, and natural gas liquids. The Company's business has oil and gas operations in three geographic areas: the United States (U.S.), Egypt, and offshore the U.K. in the North Sea (North Sea). APA also has active development, exploration, and appraisal operations ongoing in Suriname, as well as exploration interests in Uruguay, Alaska, and other international locations.
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.